Memphasys Limited (ASX: MEM) - Share Price
- Current share price for MEM : $0.004
Memphasys Limited's current share price is $0.00. This constitutes a share price movement of 0% when compared to its closing share price of $0.00 seven days ago. Relative to today's opening stock price, the MEM stock price is unchanged.
MEM General Information +
| ASX Code | MEM |
| Website | N/A |
| Industry/Sector | Life Sciences Tools & Services |
| Market Cap ($M) | 12 |
| MEM Share Price | $0.004 |
| Day High | $0.004 |
| Day Low | $0.004 |
| Last Close | $0.004 |
| MEM Share Price Movement | - ( No change ) |
Prices as at 14:06, 12 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Memphasys Limited (MEM) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Memphasys Limited (MEM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Memphasys Limited (MEM) price-sensitive announcements
MEM - Felix Global Commercial Momentum Extends to New Zealand
Memphasys Limited announced that it has secured its first New Zealand commercial agreement
Memphasys Limited (MEM)
9 Nov 2026 | 9:13 AM
9 Nov 2026 | 9:13 AM
MEM - Quarterly Activities/Appendix 4C Cash Flow Report
Memphasys Limited’s Quarterly Activities Report and Appendix 4C for the quarter ended 30 S
Memphasys Limited (MEM)
13 Oct 2026 | 9:14 AM
13 Oct 2026 | 9:14 AM
MEM - Memphasys receives A$3.5 million from Peters Investments
Memphasys Limited (ASX: MEM) announced that long-term major shareholder Peters Investments
Memphasys Limited (MEM)
29 Sep 2026 | 9:44 AM
29 Sep 2026 | 9:44 AM
MEM - Potential Expedited FDA Pathway to US IVF Market
Memphasys Limited (ASX: MEM) announced that a Board reassessment of the US regulatory stra
Memphasys Limited (MEM)
25 Sep 2026 | 9:35 AM
25 Sep 2026 | 9:35 AM
Memphasys Limited (MEM) Recent ASX Announcements
MEM Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$4.10 | -$0.20 | 33.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$4.14 | -$0.10 | -33.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$4.44 | -$0.20 | 5.90% | 0.00 | 0.00 | 0.00% | 0.0% |
MEM Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| Memphasys Limited (MEM) | $12M | 0.3333 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
MEM Directors
| Name | Position | Start Date |
|---|---|---|
| Mr David Raymond Tasker | Non-Executive Chairman, Non-Executive Director | 19 May 2026 |
| Mr Marjan Mikel | Non-Executive Director | 19 Jun 2025 |
| Mr Mathew Leslie Watkins | Non-Executive Director | 20 Oct 2025 |
| Ms Melissa Peters | Non-Executive Director | 29 Sep 2026 |
Memphasys Limited (MEM) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 18 Sep 2026 | TASKER, David | Issued | Indirect Shares | 8,000,000 | $0.005 | $40,000.000 |
| 19 Dec 2025 | MIKEL, Marjan | Issued | Direct Shares | 6,666,667 | $0.003 | $20,000.000 |
| 19 Dec 2025 | EDWARDS, Lindley | Issued | Direct Shares | 5,848,840 | $0.003 | $17,546.520 |
See all changes in directors' interest & trades for Memphasys Limited (MEM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
MEM Management
| Name | Position |
|---|---|
| David Ali | Chief Executive Officer |
| Andrew William Metcalfe | Company Secretary |
| Stefan Ross | Company Secretary |
| Hassan Bakos | Other Corporate Officer |
MEM Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Memphasys Limited (MEM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 261,564,791 (9.19%) | Peters Investments Pty Ltd |
| 165,000,000 (5.35%) | Gowans Superfund |
MEM Calendar of Events
| Date | Event |
|---|---|
| 30 August 2027 | Report (Annual) |
| 30 August 2027 | Report (Prelim) |
| 26 February 2027 | Report (Interim) |
| 25 November 2026 | AGM |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
